Editas Medicine competitive analysis

Explore Editas Medicine's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Apr 9, 2026
Patent NumberPublication DateTitleTotal Oppositions
Dec 21, 2022Crispr/Cas-Related Methods And Compositions For Treating Cystic Fibrosis1
Mar 7, 2018Crispr-Related Methods And Compositions With Governing Grnas2

Latest PTAB cases involving Editas Medicine

Discover the latest PTAB cases involving Editas Medicine, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Editas Medicine with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Apr 9, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
EDITAS MEDICINE - 3 - -
GRUND32 - - -
JAMES POOLE158 - - -